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Abstract
Sanfu acupoint herbal patching (SAHP) is a unique traditional Chinese medicine therapy, which has become popular for preventing
acute attack of respiratory diseases such as asthma and chronic obstructive pulmonary disease, in many regions of mainland China.
However, the knowledge about its users is lacking, especially the characteristics of the users and their experience and perspectives.
To investigate the demographics of users, conditions for its use and the previous experience of SAHP, as well as users’
perspectives to provide baseline information for its practice.
A cross-sectional consecutive-sample survey was conducted at outpatient departments from 3 traditional Chinese medicine
hospitals in northern China. Each participant completed a questionnaire, after informed consent. Data description and analyses were
done using SPSS 20.0.
Among 949 SAHP users from 3 hospitals, female was predominant (n=592; 62.4%), aged from 2 to 96 years (median=52
years). 64.7% (380/587) of regular users have applied consecutively for 3 years or over, and the self-perceived satisfaction rates
of respiratory diseases were from 45.9% to 77.7%. Positive attitude toward traditional Chinese medicine was the top reason for
choosing SAHP. 42.4% of users held a motivation of being cured by SAHP and with great outcome expectancy on SAHP
(70.8%).
SAHP users were mainly female adults or elderly population; more than half were regular users, who predominantly used SAHP for
various chronic respiratory diseases during their stable stage. The majority of users expressed satisfaction to previous SAHP for their
respiratory diseases. 42.4% of users held a motivation of being cured by SAHP and with great outcome expectancy on SAHP
(70.8%). The findings from this survey deserve further clinical trials for their clinical effectiveness.
Abbreviations: SAHP = sanfu acupoint herbal patching, STROBE = the strengthening the reporting of observational studies in
epidemiology, TCM = traditional Chinese medicine.
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Fu is a special period in lunar calendar when yang (a moral
connotation of light)[1] is the strongest in both human body and
outside environment.[2] There are 3 or 4 fus every year, each of
them lasting 10 days, and together are called as sanfu (dog days).
Usually, sanfu starts from middle of July to middle of August.
According to traditional Chinese medicine (TCM), applying
certain therapies during sanfu could help to decrease or even stop
the recurrence of winter-susceptible diseases (winter diseases) by
taking advantage of inner-body and outside strongest yang qi
during sanfu period, which was called “winter diseases treated in
summer”.[3] And among several therapies, sanfu acupoint herbal
patching (SAHP) is the most common one in China. SAHP is a
TCM external therapy that combines the function of herb, the
stimulation of acupuncture points and environment which only
applied during sanfu.[4] The origin can be traced back to Zhang
Shi Yi Tong in 1695.[5] According to TCM, when yang deficiency
fails to control yin, some diseases always recur in winter, SAHP
keep body healthy by means of absorbing yang from the
environment, strengthening yang inside the body, and rebalancing
yinandyang.Consequently, thebody’s disease-resistant ability can
be improved to defense against the diseases that occurred in the
cold days.[6] Modern biologists have discovered that there are the
convergent points of the organs’ qi and blood along meridians.[7]
Placing anherbal patch directly on the acupuncture point therefore
helps to maximize its therapeutic effects, with the aggregate effect
being a combination of herbal action plus the acupoint response
acting synergistically.[8] The details of SAHP and its practice
procedure could be found in Fig. 1.
Generally, SAHP could be applied to different diseases
depending on selected herbs and acupuncture points, including
rheumatism and rheumatoid disease, joint and muscle disease,
gastrointestinal disease, and etc. According to our previous
bibliometric analysis on the clinical trials of SAHP,[9] respiratory
disease was the top target condition. Currently, there are 2 kinds
of SAHP in clinical use, 1 is pharmaceutical factory made with
patent herbal patch, usually used in community-based medical
centers; other one is hospital pharmacy made which is more
flexible with different conditions, can be applied in different
departments of hospitals.
SAHP earns a highly popularity in China;[10] every sanfu
period, thousands of thousands people are actively rushing into
different medical institutions to seek SAHP application. Although
there is no published data about the prevalence of SAHP use, the
number of medical institutions providing SAHP service is
increasing according to official data. In 2014, the State
Administration of Traditional Chinese Medicine reported there
had been 620 medical institutions providing SAHP in Beijing,[11]Figure 1. Photographs of SAHP and its practice procedure. A, SAHP (Sanfu acupo
hn.cnr.cn/. SAHP=sanfu acupoint herbal patching.
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an increase of 13.14% compared with 2013. These
institutions covered different levels of general hospitals, special
hospitals, and community health centers. Some hospitals even use
their staff canteen as SAHP application site and employ medical
students as applier with a short training temporarily to relieve
stress from such substantial amount of SAHP users in such short
period. In addition, there have been clinical trials conducted in
mainland China, Hong Kong, and Taiwan to test effectiveness
and safety of SAHP.[13,14] And several systematic reviews have
reported that SAHP might be effective and safe on the prevention
of chronic obstructive pulmonary disease, allergic rhinitis, and
asthma.[15–17]
Faced with such substantial amount of SAHP users, we just
wondered: who are they? Why they choose SAHP? How about
their previous use of SAHP? What are their perspectives,
expectations, and experience toward SAHP? However, no
complete epidemic data was available. To find out such answers
could give important hints to practitioners and healthcare policy
makers when making decisions about practicing SAHP, as
evidence-based medicine requires that patients should be fully
considered for medical decisions as well, with regard to their
characteristics, subjective attitudes, treatment history, and future
plan on treatment.[18] Besides, expectation to the treatment might
have an influence on patients’ engagement, adherence, and
outcome measures.[19–24] Furthermore, previous treatment
experience may influence the healing process, as shown by
classical conditioning studies.[25] Therefore, in clinical practice,
patients’ related information need to be validated and accessible
by physicians. In addition, these data also might be the base for
related authorities to make healthcare decision.
Based on the previous study,[9] respiratory disease was the top
target condition. Hence, we chose people with respiratory
diseases as our investigation population. In order to inform
clinical practice, this study was to explore the demographics,
medical characteristics, history, motivations, and expectations of
SAHP users from respiratory departments in 3 tertiary hospitals
in northern China.
2. Methods
This survey was prepared according to the Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE)
Statement.[26]2.1. Study design
This cross-sectional study surveyed a consecutive sample of
SAHP users from the outpatient respiratory departments of 3
TCM hospitals in Beijing, Jinan/Shandong, and Ningcheng/Innerint herbal patching). B, Physician is applying SAHP therapy. Quoted from http://
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was set to 300 participants. The study protocol was approved by
the Institutional Review Board at Beijing University of Chinese
Medicine (Approval No. 2015BZHYLL0408). Each participant
got informed consent. All the questionnaire written by adult
patients or parents of children, except for elders who are unable
to read and write, our investigator would help to read the
contents to them and fill the questionnaires for them.2.2. Setting
We recruited outpatient participants from respiratory depart-
ment at 3 TCM hospitals, which are located in northern China.
Two of them (Beijing, Jinan/Shandong) are teaching hospitals
(tertiary-level), while the other one (Ningcheng/Inner Mongolia)
is nonteaching hospital (tertiary-level hospital). Each site has 3 to
5 master students as investigators to screen the eligibility (see
below) of participants and to disseminate questionnaires. Because
participants must come to hospitals to receive SAHP during the
first 3 days of first fu, our investigation was conducted during this
special period.
2.3. Participants
Eligibility criteria were: physician-confirmed diagnosis of
respiratory disease or previously diagnosed respiratory disease,
age 2 years or older, the ability to attend 3 SAHP treatment
sessions within 40 days. Participants should be excluded whomet
the following exclusion criteria: skin allergy to the patching herbs
and inability to understand the contents of questionnaire.
2.4. Variables and measurement
Eligible participants were seen at their hospital by a master
student for baseline assessment. After being informed about
SAHP therapy, participants then completed a questionnaire. For
elders who were unable to read and write, investigators would
help them to complete all the questions using the same predefined
instructions; whereas for the younger who are too young to be
able to understand, their supervisor would be the replier (Their
supervisors should be living with the participants for at least 1
year). Investigators should check the completeness of each
questionnaire in case of missing information.
Questionnaire was a self-defined baseline assessment battery,
which was constituted of 5 parts: general information:
demographic data (sex, race, birth data, contact information),
socioeconomic data (employment status, occupation, educational
status, insurance status), medical data (confirmed or self reported
respiratory disease categories, course, and stage), reasons for
choosing SAHP (2 questions; routes to know, reasons to choose
SAHP), SAHP therapy history (3 questions; when was the first
time, for which disease, self-perceived effectiveness), motivation
(being cured, recurrence prevention, symptom alleviation, and
respiratory disease prevention), expectation for current SAHP
therapy (have a try, have a great outcome expectancy on SAHP),
whether to refer SAHP to significant others.
2.5. Bias
We tried hard to reduce potential sources of bias. First, we
collected data consecutively, to decrease the selection bias from
nonrandomization sample. Furthermore, the questionnaire used
was designed by 3 experts with traditional Chinese medicine and
clinical epidemiological background as well to make certain of its3
validation. In addition, our pilot survey of 20 people showed the
retest reliability of our instrument was 0.92.2.6. Statistical methods
An electronic database was established by using EpiData version
3.1 (The EpiData Association, Odense, Denmark). Data then are
transferred into SPSS software (version 20; IBM Corporation,
Armonk, NY) by performing double entry to ensure the data
transfer was correct. Respondents were grouped into 6 age
groups for analysis: preschool age=younger than 6 years,
adolescents=7 to 14 years; young people=younger than 24
years, mature adults=25 to 44 years; middle-age adults=45 to
64 years, and older people=65 years and older. Frequency,
percentage, median, range, means, and standard deviations, x2
test, and one-way ANOVA were applied in description of
variables.3. Results
3.1. User participation rates
Out of the 1200 questionnaires distributed, 1008 (84%)
questionnaires were returned; 59 were incomplete because of
refusing to participate halfway. The survey was completed during
July 2015. The final analytic sample included 949 participants
who were taking SAHP.3.2. User demographic and medical data
Table 1 shows the frequency distribution of the users’ socio-
demographic variables and Table 2 describes the medical
variables. Overall, the users were predominantly female (n=
592; 62.4%); aged from 2 to 96 years (median=52 years, (Q1,
Q3) (33,62)); of Han ethnic background (n=912; 96.1%); and
SAHP insurance covered (n=464; 48.9%). This sample of 949
participants contained 15.1% juveniles (n=144), 2.3% young
people (n=22), 21.7% mature adult (n=206), 38.9% middle-
aged adult (n=369), and 21.9% older people (n=208). In
addition, among participants who aged 18 years old or more,
most had up to a high school education (n=535; 66.5%);
employed (n=465; 57.8%), or retired (n=305; 37.9%). Except
age and gender, other sociodemographic variables (such as
ethnicity, education, employment, and insurance status) have
shown significant statistical difference (Table 1).3.3. Conditions for SAHP application
Table 2 shows the current primary conditions of SAHP
application. SAHP was mostly applied in participants with
chronic bronchitis (n=368; 38.8%), followed by asthma (n=
202; 21.3%) and rhinitis (n=162; 17.1%); while the chronic
cough was on the lowest rank (n=43; 4.5%). The primary
disease duration was from 3 months to 55 years, with a median 5
years, (Q1,Q3) (3 months,10 years), and most of these diseases
were in a stable status (n=761; 80.2%).
3.4. Status and satisfaction on previous SAHP application
Table 2 gives the history of SAHP application and Fig. 2
provides the distribution of sustained SAHP application
duration by year. More than half of the users were regular
users who have received SAHP for more than 1 year (n=587;
61.9%). Among them, 380 (64.7%) users applied consecutively
Table 1
Sociodemographic profile of the 949 SAHP users.
Variables Beijing n=330 (%) Jinan/Shandong n=305 Ningcheng/Inner Mongolia n=314 Total n=949
Age, y Median (Q1,Q3) 52 (33,62) F=1.076; P=0.221
∼6 5 (1.5) 31 (10.2) 43 (13.7) 79 (8.3)
7–17 6 (1.8) 17 (5.6) 42 (13.4) 65 (6.8)
18–24 7 (2.1) 11 (3.6) 4 (1.3) 22 (2.3)
25–44 76 (23.0) 85 (27.9) 45 (14.3) 206 (21.7)
45–64 137 (41.5) 100 (32.8) 132 (42.0) 369 (38.9)
65∼ 99 (10.4) 61 (0.2) 48 (15.3) 208 (21.9)
Gender x2=0.516; P=0.773
Male 128 (38.8) 110 (36.1) 119 (37.9) 357 (37.6)
Female 202 (61.2) 195 (63.9) 195 (62.1) 592 (62.4)
Ethnicity x2=21.199; P<0.001
Han 322 (97.6) 301 (98.7) 289 (92.0) 912 (96.1)
None-han 8 (2.4) 4 (1.3) 25 (8.0) 37 (3.9)
Level of education
∗
n=319 n=257 n=229 n=805 x2=62.792; P<0.001
Master or above 22 (6.9) 18 (7.0) 1 (0.4) 41 (5.1)
College 190 (3.1) 117 (45.5) 51 (22.3) 358 (44.5)
High school 55 (17.2) 48 (18.7) 33 (14.4) 136 (16.9)
Primary or below 52 (16.3) 74 (28.8) 144 (62.9) 270 (33.5)
Employment status
∗
x2=16.706; P=0.010
Employed 161 (50.5) 160 (62.3) 144 (62.9) 465 (57.8)
Unemployed 5 (1.6) 3 (1.2) 4 (1.8) 12 (1.5)
Retired 147 (46.1) 86 (33.5) 72 (31.4) 305 (37.9)
Students 6 (1.9) 8 (3.1) 9 (3.9) 23 (2.9)
Insurance status x2=334.234; P<0.001
SAHP covered 289 (87.6) 121 (39.7) 54 (17.2) 464 (48.9)
SAHP not covered 41 (12.4) 184 (60.3) 260 (82.8) 485 (51.1)
The denominators do not add up to 100% because of rounding off.
∗
Age ≧ 18 years old participants were reported for this variable.
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consecutively 3 years or over (n=173; 45.5%). In addition,
207 (35.5%) users reported unconsecutive use of SAHP. The
mean of the total out-of-pocket expenditure on SAHP ranged
from 150 to 300 RMB (15.69–31.38 GBP) per sanfu.
After combined “very satisfied” with “satisfied,” the general
outcome satisfactory rate of previous use of SAHP was 72.7%
(314/432) (Fig. 3). For the association between characteristics of
users and their satisfaction on previous SAHP use, none ofTable 2
Medical characteristics and history of SAHP application among the
Variables n %
Current respiratory disease
∗
Asthma 202 21.3
Chronic bronchitis 368 38.8
COPD 52 5.5
Pneumonia 37 3.9
Pharyngitis 146 15.4
Rhinitis 162 17.1
Chronic cough 42 4.4
Common cold prevention 100 10.5
Current primary disease duration
Median=5 y, (Q1,Q3) (3 mo, 10 y)
The primary disease status
Stable 761 80.2
Acute attack 88 9.3
Nondisease 100 10.5
COPD= chronic obstructive pulmonary disease, Q1=1st quartile, Q3=3rd quartile.
∗
The denominators do not add up to 100% because of rounding off; the total is more than 587 beca
4
statistically significant results was found for the different
subgroups of SAHP users in terms of their sociodemographic
characters (such as age, gender, education level, and insurance
status) (Table 3). However, the general satisfactory rates of
previous SAHP use in different conditions varied from 45.9%
(rhinitis; 39/85) to 82.4% (pharyngitis; 70/85). Among them,
general satisfactory rates for the outcome of other respiratory
diseases were different: common cold prevention was on the
second rank with 77.4% (48/62), chronic cough was on the third949 users.
Variables n %
New user 362 38.1
Regular user 587 61.9
Sustained use 380 64.7
Nonsustained use 207 35.3
Previous primary target disease
∗
(regular user)
Asthma 108 18.4
Chronic bronchitis 221 37.7
COPD 31 5.3
Pneumonia 22 3.8
Pharyngitis 85 14.5
Rhinitis 85 14.5
Chronic cough 20 3.4
Common cold prevention 62 10.6
Other condition 23 3.9
(nonrespiratory disease)
use some users had more than 1 target disease.
Figure 2. Sustained SAHP application years.
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132/221), pneumonia was the fifth (59.1%; 13/22), others were
near to 50%.
3.5. Information source to know SAHP and reasons to
choose SAHP
Figure 4 summarizes the users’ sources of information about
SAHP. Health professional introduction (412; 43.4%) and word
of mouth by acquaintance (including family members, friends)Figure 3. Satisfaction and motivation on SAHP among users. A, The general ou
Table 3
Sociodemographic characters and satisfaction on previous SAHP us
Variable Satisfied
∗
(n=314)
Age, y Median (Q1,Q3) 51.5 (32,65)
∼6 28 (8.9)
7–17 29 (9.2)
18–24 8 (2.6)
25–44 56 (17.8)
45–64 114 (36.3)
65∼ 112 (35.7)
Gender
Male 118 (37.6)
Female 196 (62.4)
Level of education
Master or above 11 (3.5)
College 117 (37.3)
High school 49 (15.6)
Primary or below 129 (41.1)
Insurance status
SAHP covered 164 (52.2)
SAHP not covered 150 (47.8)
The denominators do not add up to 100% because of rounding off.
∗
Satisfied includes 2 choices (very satisfied and satisfied).
† Unsatisfied includes 3 choices (just so-so, unsatisfied, and very unsatisfied).
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(397; 41.8%) were the main 2 sources, while the television (139;
14.7%) and newspaper (99; 10.4%) was relatively low.
Figure 4 shows the reasons for choosing SAHP. The users’
main reasons of choosing SAHP were trust TCM (n=372;
39.2%), and physician introduction (n=331; 34.9%), and safe
(no adverse reaction) (n=287; 30.2%), whereas only 11.9% of
users (n=113) just followed the example of other SAHP users.
When the question turned to be a multiple one, the answers were
relatively dispersed. The primary reason for choosing SAHP of
respondents were still trust on TCM (n=321; 33.8%), followed
by physician introduction (n=199; 21%); However, curious and
want to experience of SAHP was up to the fifth reason (n=74;
7.8%); whereas no pain (n=17; 1.8%), safe (no adverse reaction)
(n=66; 7%), and convenient (n=73; 7.7%) were down to the
last one, last third, and fourth, respectively.3.6. Motivations and expectancy on SAHP
Figure 3 demonstrates the motivation on SAHP among the 949
users.Of the 900users’ responses on themotivationof thefirst time
use of SAHP, 402 users were with hope of being cured (42.4%),
second one was to prevent attack of respiratory disease (n=276;
29.1%), alleviating symptom was ranked in third (n=209; 22%),
only a few wished to prevent respiratory disease (n=62; 6.5%).
More than half respondents hold “have a try” (n=491;
51.7%), while the rest thought “have a great outcome expectancytcome satisfactory rate on previous SAHP. B, Users’ motivations on SAHP.
e from univariate analysis (n=432).
Unsatisfied† (n=118)
Median (Q1,Q3) 53.5 (39.5,68) x
2=7.571; P=0.182
8 (6.8)
3 (2.5)
2 (1.7)
20 (17.0)
52 (44.1)
33 (28.0)
x2=0.003; P=0.956
44 (37.3)
74 (62.7)
x2=4.744; P=0.192
8 (6.8)
47 (39.8)
23 (19.5)
38 (32.2)
x2=0.139; P=0.710
64 (54.2)
54 (45.8)
Figure 4. Information sources and reasons to choose SAHP among the 949
users. A, Users’ information sources of SAHP. B, Users’ reason to choose
SAHP. C, Users’ primary reason to choose SAHP. CM=conventional
medicine, SAHP=sanfu acupoint herbal patching, TCM= traditional Chinese
medicine.
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respondents reported that they would recommend SAHP to
others (n=858; 90.5%), and even without reimbursement, still
majority of users would take SAHP (n=762; 80.3%).4. Discussion
4.1. Primary findings
Users were mainly represented by middle or older population
group (60.8%); these older adults predominantly used SAHP for
various chronic diseases on their stable stage. It is worth noting
that the juveniles (15.1%) and young people (2.3%) appeared in
our sample. Majority of this young people using SAHP was for
common cold prevention.
More than half were regular users; while only half of regular
users applied consecutively 3 years or longer. Although the
satisfaction on previous SAHP use was not related to user’s
age, gender, higher education, and insurance status, different
conditions showed different general satisfactory rates. Regular6
users’ self-perceived general satisfactory rate of SAHPprevious use
on commoncoldpreventionwas relatively high (77.4%); seconded
was prevention or treatment of other diseases, around 50%, in
which, pharyngitis was the highest one (77.7%). It gives a hint that
SAHPusemight bebeneficial upper respiratorydiseases.However,
we also need to be aware that these conditions are self-healing.
Users’ source of information about SAHP was mainly through
physician introduction; whereas even there is little encourage-
ment from health personnel, word by mouth by friends and
acquaintance were not ignored. Reasons for choosing SAHPwere
various; however, trust TCMwas themain reason. Almost half of
users hold a motivation of being cured by SAHP and with great
outcome expectancy on SAHP. Even if SAHP is turned to out-
pocket medical service, 80.3% users are still willing to choose
SAHP. And 90.5% users stated that they would like to
recommend SAHP to their significant others.4.2. Strengths and weaknesses of the study
Based on our knowledge, it is the first multiple-site survey to
describe the characteristics and subjective points on SAHP which
could provide an up-to-date picture on the current state of
provision of SAHP in northern China. Although 3 tertiary-level
TCMhospitals investigated located innorthernChina, their source
of users might be different due to their geographic locations (1 in
national capital, 1 in provincial capital while the third one at
county-level). And the sample from3 sites owns different ethnicity,
education level, employment status, and insurance status distribu-
tion. Based on such diversity, our sample might be more
representative. On the other hand, we did not select the
investigation sites by random method, which might result in
limited generalizability of this finding. Butwe tried to take samples
consecutively to minimize potential bias. Besides, our results may
not be representative for users from all levels TCM hospitals,
especially the lower-level TCM hospitals and western medicine
dominated hospitals. Finally, our sample is selectively focusing on
SAHP users with respiratory diseases so the result may be affected
by the specificpopulation. Ideally, itwouldbe interesting to include
nonrespiratory disease users in our study. However, it was not
done as this was not our primary objective of the survey.4.3. Implications for physicians, policymakers, and future
research
Compared with the group of juveniles, middle-age, and old adults
SAHP users (75.9%), young adults SAHP users group only
occupied 2.3%, which is the smallest one in our survey. The
possible reason for this is that the susceptible population to
respiratory disease is mainly juveniles and elder adults. However,
whether there exist some other reasons or not is still unclear; for
example, they do not know SAHP or are not familiar with SAHP?
SAHP were widely used by female participants (62.4%)
compared with their male counterparts (37.6%). In some
Western countries, women are increasing utilizing CAM and
some surveys also supported our finding.[27,28] This is probably
due to: females might be more concerned about their diseases,
even for the nonfatal disease at stable stage. However, further
investigations are needed to confirm these conclusions.
Although nearly half of our sample was covered by insurance,
majority of users expressed that they could afford the SAHP
therapy even at their own expenses. This is remarkably conflicting
with the popular saying “no insurance, no SAHP” by some
physicians. When developing an evidence-based guideline,
[2] Lorraine W. San fu moxibustion and lung-related disorders. J Chin Med
Zhou et al. Medicine (2016) 95:49 www.md-journal.comwhether patients accept an intervention or not sometimes only
depends on the patients’ affordability.[18]Hence, thisfindingmight
help to stimulate future clinical trials for their preventive effect on
respiratory diseases so as to inform current practice.
It is worthy noting that some of our sample reported their
motivations prevent respiratory disease or its recurrence
(35.6%). Currently, we could find many clinical studies of
SAHP treat on people with different respiratory diseases;
however, there remains insufficient evidence of its benefit for
preventing respiratory diseases, and if beneficial, whether it is
cost-effective compared with other preventing medical interven-
tion. This “evidence gap” provides a major challenge to the
research community to develop the evidence base further.
We have provided an important insight into the history of
SAHP use. There are 2 research proposals that emerge from our
study. First, generally, TCM doctors suggested that SAHP is
applied at least for 3 consecutive years,[29] so we suggest that a
deep reason analysis is needed: to understand more about the
treatment strategy. Second, we noted that the longest application
duration was 18 years in our sample. For users with such higher
compliance, we propose an in-depth interview to explore SAHP
users’ experience and self-perceived outcome on SAHP, which
might provide hints to future research and practice.
Trusting TCM was the top reason why choose SAHP in our
survey should be noted. In this survey, the age of users is relatively
old, with a mean of 52 years old. Within this age group, taking
TCM is very common during their childhood. In other words,
special affection of TCM rooted in their mind. Lee et al[30]
reported complementary and alternative medicine was more
likely to be used if patients held strong beliefs about it or grow in a
complementary and alternative medicine culture background.
Whether there are relationships between TCM beliefs and higher
satisfactory rate or higher expectancy in our study, is not
answered. This may give future researchers a hint: before we
introduce SAHP to international clinical context, a trial
considering TCM culture as group factor is necessary.
In this survey, we found a desire from the users to recommend
SAHP to others, fairly high frequency of word by mouth
information source and decent general outcome satisfactory rate
on previous SAHP. These may reflect that the subjective feelings
of users on SAHP are accepted.
Due to the particularity of investigate time (only conducted in
the first day of first session), it is impossible to assess the adverse
events of SAHP in our survey. However, according to the
literature review,[14] this therapy appears safe. There were almost
no adverse events reported and only several local reactions were
present, such as skin itch, redness, and small blisters, and these
reactions could gradually vanish after removing patches.
5. Conclusions
By means of analyzing comprehensively 949 SAHP users from 3
TCM hospitals in northern China, we found the demographics of
users, conditions for its use and the previous experience of SAHP, as
well as users’ perspectives. These findings may provide baseline
information for SAHPpractice and reflect that the subjective feelings
of users on SAHP are accepted. Further, clinical trials are urgently
needed to validate SAHP’s rationale use. We hope that this survey
can stimulate much research on this unique TCM therapy in China.References
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